Cash Flow Statement

Amortizatization of Intangibles Capital Expenditures Cash from Financing Activities Cash from Investing Activities Cash from Operations Change in Account Payables Change in Accured Expenses Change in Acquisitions & Divestments Change in Cash Depreciation & Amortization (CF)Free Cash Flow Gains from Investment Securities Gains from Sales and Divestitures Net Cash Flow Net Income Non-cash Items Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Income Statement

Others

Ratios

Atea Pharmaceuticals (AVIR) Other financing activities (2020)

Atea Pharmaceuticals (AVIR) has 1 years of Other financing activities data on record, last reported at $913000.0 in Q3 2020.